﻿<?xml version="1.0" encoding="utf-8"?><?xml-stylesheet title="XSL_formatting" type="text/xsl" href="cms1260795.aspx"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><language>en-gb</language><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><lastBuildDate>Mon, 06 Oct 2008 19:58:52 GMT</lastBuildDate><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><description><![CDATA[aidsmap.com news feed : aidsmap news]]></description><copyright>Copyright NAM 2008</copyright><link>http://www.aidsmap.com</link><atom:link href="http://www.aidsmap.com/cms1260794.aspx" rel="self" type="application/rss+xml" /><image><title><![CDATA[aidsmap.com news feed : aidsmap news]]></title><url>http://www.aidsmap.com/files/file1002517.gif</url><link>http://www.aidsmap.com</link><width>122</width><height>44</height></image><ttl>15</ttl><item><title><![CDATA[High early mortality after starting antiretroviral treatment in Africa]]></title><link>http://www.aidsmap.com/en/news/3BADC5D7-D625-4B9B-B875-3D766B8DCD8D.asp</link><author>Kelly Morris</author><guid isPermaLink="false">3BADC5D7-D625-4B9B-B875-3D766B8DCD8D</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[Patients starting antiretroviral therapy in sub-Saharan Africa have a high rate of mortality, according to a review article published in the October 1st edition of AIDS. Many of the deaths occurred in the first three months of treatment, and there was also notable mortality in the interval between joining a treatment programme and actually starting therapy.
]]></description><category>Africa news</category><category>Palliative care news</category></item><item><title><![CDATA[Nobel prize awarded to French discoverers of HIV]]></title><link>http://www.aidsmap.com/en/news/DC84126A-9683-482C-8954-728DA265C6FF.asp</link><author>Michael Carter</author><guid isPermaLink="false">DC84126A-9683-482C-8954-728DA265C6FF</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[The French scientists who discovered HIV have been awarded the Nobel Prize for Medicine. The prize will be shared with the researcher who linked human papilloma virus and cervical cancer.
]]></description><category>Basic science news</category></item><item><title><![CDATA[Fall in number of undiagnosed HIV infections in the US]]></title><link>http://www.aidsmap.com/en/news/EEC288ED-49D4-4E4B-8111-9F696190B9BB.asp</link><author>Michael Carter</author><guid isPermaLink="false">EEC288ED-49D4-4E4B-8111-9F696190B9BB</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[Latest HIV prevalence figures show that there has been a fall in the number of undiagnosed HIV infections in the US. The figures, reported in the October 3rd edition of Morbidity and Mortality Weekly Report (MMWR), also show that there were just over 1,100,000 people living with HIV in the United States at the end of 2006. 
]]></description><category>Statistics and epidemiology news</category><category>World policy News</category></item><item><title><![CDATA[Higher levels of drug resistance seen after first-line NNRTI failure than boosted PI failure: meta-analysis]]></title><link>http://www.aidsmap.com/en/news/5D43C654-A08D-40C8-8777-84DA318F9DD8.asp</link><author>Derek Thaczuk</author><guid isPermaLink="false">5D43C654-A08D-40C8-8777-84DA318F9DD8</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[In a meta-analysis of data from nearly 8000 patients reported in Clinical Infectious Diseases, researchers found significantly fewer drug resistance mutations, including NRTI-associated mutations, in people who had experienced treatment failure while taking first-line HIV treatment based on boosted PIs than in people taking NNRTI-based therapy. 
]]></description><category>Resistance news</category></item><item><title><![CDATA[Wide variation found in anal HPV viral loads in HIV-positive men]]></title><link>http://www.aidsmap.com/en/news/C3D22BCF-F462-4442-8D2F-BA01EB8CC0D5.asp</link><author>Derek Thaczuk</author><guid isPermaLink="false">C3D22BCF-F462-4442-8D2F-BA01EB8CC0D5</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[High rates of anal human papilloma virus infection have been found in an Italian cohort of HIV-positive men. A study, published in the October 1st edition of AIDS, also reports that the most common strains of human papilloma virus were those which carry a low risk of anal cancer. Human papilloma virus viral load was highly variable and did not appear to be linked to the strain of the virus or the strength of each individual patient’s immune system. 
]]></description><category>HIV and cancer news</category><category>HIV and sexual health news</category></item><item><title><![CDATA[Offering rapid point-of-care tests would increase uptake of HIV testing]]></title><link>http://www.aidsmap.com/en/news/B7016D27-144C-4C57-9126-42671B092BB5.asp</link><author>Roger Pebody</author><guid isPermaLink="false">B7016D27-144C-4C57-9126-42671B092BB5</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[Over half the people who decline to take an HIV test would do so if they had the option to take a test that gave the result in 20 minutes, report researchers in the August 2008 issue of the International Journal of STD and AIDS. The authors recommend that rapid point-of-care tests should be made routinely available in all genitourinary medicine (GUM) clinics.
]]></description><category>UK news</category><category>Developed world news</category><category>Prevention news</category></item><item><title><![CDATA[Low rate of spontaneous hepatitis C clearance in patients with HIV; early HIV treatment recommended for those with chronic hepatitis C infection]]></title><link>http://www.aidsmap.com/en/news/9DD3F54A-F8E9-4920-9220-8A8F8C474ED0.asp</link><author>Michael Carter</author><guid isPermaLink="false">9DD3F54A-F8E9-4920-9220-8A8F8C474ED0</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[Approximately a quarter of patients coinfected with HIV and hepatitis C virus spontaneously clear infection with hepatitis C, according to a study conducted by European investigators and published in the November 1st edition of the Journal of Infectious Diseases. 
]]></description><category>Hepatitis news</category><category>Starting treatment news</category></item><item><title><![CDATA[Cluster of multi-drug resistant HIV transmissions in Seattle]]></title><link>http://www.aidsmap.com/en/news/6CCAD28F-98AB-4F8C-B3A7-04F63E33FD2D.asp</link><author>Michael Carter</author><guid isPermaLink="false">6CCAD28F-98AB-4F8C-B3A7-04F63E33FD2D</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[Investigators in Seattle have reported a cluster of nine HIV infections involving resistance to multiple drugs from all the three main classes of antiretrovirals. The report is published in the October 1st edition of the Journal of Acquired Immune Deficiency Syndromes.
]]></description><category>Resistance news</category><category>Gay men news</category><category>Prevention news</category></item><item><title><![CDATA[Hypersensitivity testing for abacavir slightly more cost-effective than tenofovir use, if both drugs equally potent]]></title><link>http://www.aidsmap.com/en/news/EDE2BB5D-B7BA-4DB7-9B11-460D7374CDC8.asp</link><author>Gus Cairns</author><guid isPermaLink="false">EDE2BB5D-B7BA-4DB7-9B11-460D7374CDC8</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[Abacavir-based regimens are slightly more cost-effective than tenofovir-based ones, a US mathematical modelling study published in AIDS has concluded. But this is only the case if patients are tested at the outset for the abacavir hypersensitivity reaction, a potentially fatal allergy to the drug.
]]></description><category>Starting treatment news</category></item><item><title><![CDATA[HIV no longer bar to granting of US visa for short visits]]></title><link>http://www.aidsmap.com/en/news/4B97D434-6BCB-481A-B0C3-E2BF3CD67F6A.asp</link><author>Michael Carter</author><guid isPermaLink="false">4B97D434-6BCB-481A-B0C3-E2BF3CD67F6A</guid><pubDate>Mon, 06 Oct 2008 19:58:52 GMT</pubDate><image /><description><![CDATA[Being HIV-positive will no longer be a bar to the granting of a visa to visit the USA, according to new rules issued by the US Department of Homeland Security.
]]></description><category></category></item></channel></rss>